https://www.pharmalive.com/wp-content/uploads/2020/06/AbbVie-and-Alpine-Immune-Ink-865-Million-Deal-to-License-Drug-for-Lupus-and-Other-Inflammatory-Diseases-BioSpace-6-18-20.jpeg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2020-06-18 12:21:572020-06-20 19:05:49AbbVie and Alpine Immune Ink $865 Million Deal